4//SEC Filing
CONKLING WILLIAM 4
Accession 0001213900-25-051157
CIK 0001359931other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:10 PM ET
Size
7.6 KB
Accession
0001213900-25-051157
Insider Transaction Report
Form 4
CONKLING WILLIAM
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-06-02+200,000→ 200,000 totalExercise: $3.30Exp: 2035-06-01→ Common Stock (200,000 underlying) - Award
Common Stock
2025-06-02+50,000→ 50,000 total
Footnotes (2)
- [F1]The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of June 2, 2025.
- [F2]25% of the shares vest on the one year anniversary of June 2, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.
Documents
Issuer
Protara Therapeutics, Inc.
CIK 0001359931
Entity typeother
Related Parties
1- filerCIK 0001852018
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 4:10 PM ET
- Size
- 7.6 KB